David Thomson
Corporate Officer/Principal bei North Carolina Central University
Profil
David Thomson is currently a Professor of Pharmaceutical Sciences at North Carolina Central University and a Vice President at Shire Human Genetic Therapies, Inc. He was previously the Chief Operating Officer at Precision BioSciences, Inc. from 2019 to 2021.
Thomson holds a doctorate degree from Yale University and the University of Toronto, and an undergraduate degree from the University of Strathclyde.
Aktive Positionen von David Thomson
| Unternehmen | Position | Beginn |
|---|---|---|
| North Carolina Central University | Corporate Officer/Principal | - |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von David Thomson
| Unternehmen | Position | Ende |
|---|---|---|
| PRECISION BIOSCIENCES, INC. | Geschäftsführer | 02.07.2021 |
Ausbildung von David Thomson
| Yale University | Doctorate Degree |
| University of Toronto | Doctorate Degree |
| University of Strathclyde | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PRECISION BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Health Technology |
